You are viewing an incomplete version of our website. Please click to reload the website as full version.

V-Rel Reticuloendotheliosis Viral Oncogene Homolog B (RELB) antibody

Details for Product No. ABIN966960, Supplier: Login to see
Antigen
  • shep
  • I-REL
  • IREL
  • REL-B
  • XRelB
  • relb-A
  • GC-rich
Alternatives
anti-Human V-Rel Reticuloendotheliosis Viral Oncogene Homolog B antibody for Western Blotting
Reactivity
Human, Mouse (Murine), Rat (Rattus)
143
100
65
Host
Rabbit
150
3
Clonality
Polyclonal
Conjugate
Un-conjugated
5
5
4
3
3
3
3
3
3
3
3
3
Application
Immunohistochemistry (IHC)
113
35
33
26
22
7
3
3
2
2
2
1
1
Supplier
Login to see
Supplier Product No.
Login to see
Request

Showcase your results, aid the scientific community, and receive a full refund.

Contribute a validation

Learn more

Immunogen The antiserum was produced against synthesized phosphopeptide derived from human RelB around the phosphorylation site of serine 552 (L-L-SP-P-G).
Specificity RelB (Ab-552) antibody detects endogenous levels of total RelB protein.
Purification The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
Alternative Name RelB (RELB Antibody Abstract)
Pathways NF-kappaB Signaling, RTK Signaling
Application Notes WB: 1:500~1:1000.
Restrictions For Research Use only
Format Liquid
Concentration 100ug/100ul.
Buffer Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol
Preservative Sodium azide
Precaution of Use This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage -20 °C
Product cited in: Pyz, Naidenko, Miyake et al.: "The complementarity determining region 2 of BV8S2 (V beta 8.2) contributes to antigen recognition by rat invariant NKT cell TCR." in: Journal of immunology (Baltimore, Md. : 1950), Vol. 176, Issue 12, pp. 7447-55, 2006 (PubMed).

Kaetzel: "The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces." in: Immunological reviews, Vol. 206, pp. 83-99, 2005 (PubMed).

Marienfeld, Berberich-Siebelt, Berberich et al.: "Signal-specific and phosphorylation-dependent RelB degradation: a potential mechanism of NF-kappaB control." in: Oncogene, Vol. 20, Issue 56, pp. 8142-7, 2002 (PubMed).